Debt-to-equity in % of Autolus Therapeutics plc from Q1 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Autolus Therapeutics plc quarterly Debt-to-equity history and change rate from Q1 2020 to Q3 2025.
  • Autolus Therapeutics plc Debt-to-equity for the quarter ending 30 Sep 2025 was 106 %, a 43.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Autolus Therapeutics plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 106 +32.3 +43.5% 30 Sep 2025
Q2 2025 89.8 +8.81 +10.9% 30 Jun 2025
Q1 2025 78 -15.4 -16.5% 31 Mar 2025
Q4 2024 67.1 -47.6 -41.5% 31 Dec 2024
Q3 2024 74.2 -11.1 -13% 30 Sep 2024
Q2 2024 80.9 +6.79 +9.16% 30 Jun 2024
Q1 2024 93.4 +31.1 +49.8% 31 Mar 2024
Q4 2023 115 +63.3 +123% 31 Dec 2023
Q3 2023 85.3 +45 +111% 30 Sep 2023
Q2 2023 74.2 30 Jun 2023
Q1 2023 62.3 31 Mar 2023
Q4 2022 51.5 31 Dec 2022
Q3 2022 40.3 30 Sep 2022
Q1 2021 26.5 +9.21 +53.3% 31 Mar 2021
Q4 2020 26.8 31 Dec 2020
Q3 2020 22.2 30 Sep 2020
Q2 2020 18.3 30 Jun 2020
Q1 2020 17.3 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.